Q1 2024 · 13F-HR
Decheng Capital LLCholdings as filed
Filed 2024-05-14 · accession 0001104659-24-060707
$745.6M
Reported value
22
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02083G100 | NVLSEUR | Alpine Immune Sciences, Inc. | $329.7M | 44.2% | 8,317,924 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $239.6M | 32.1% | 5,458,810 | Common | SOLE |
| 98943L107 | ZNTL | Zentalis Pharmaceuticals Inc. | $33.1M | 4.44% | 2,099,583 | Common | SOLE |
| 452327109 | ILMN | Illumnia, Inc. | $17.7M | 2.38% | 129,067 | Common | SOLE |
| G10830100 | BYSI | BeyondSpring Inc. | $17.7M | 2.37% | 4,958,143 | Common | SOLE |
| 03969F109 | RCUS | Arcus Biosciences, Inc | $16.4M | 2.20% | 869,790 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $11.7M | 1.57% | 65,772 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $11.1M | 1.49% | 347,835 | Common | SOLE |
| 29446K106 | EQ | Equillium Inc. | $10.3M | 1.38% | 4,447,308 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $9.0M | 1.21% | 850,000 | Common | SOLE |
| G4444C102 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $8.4M | 1.12% | 166,600 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $7.4M | 0.99% | 157,958 | Common | SOLE |
| 88025u109 | — | 10x Genomics, Inc. | $7.3M | 0.99% | 195,835 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $6.6M | 0.88% | 94,043 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP-ADR | $4.8M | 0.65% | 86,363 | Common | SOLE |
| N5749R100 | 2GH | MERUS NV | $4.6M | 0.61% | 101,798 | Common | SOLE |
| 05153U107 | AURA | Aura Biosciences, Inc. | $4.0M | 0.54% | 515,555 | Common | SOLE |
| 229790100 | HLTHQ | Cue Health Inc. | $1.7M | 0.23% | 8,980,909 | Common | SOLE |
| 747324101 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | $1.4M | 0.19% | 326,810 | Common | SOLE |
| 00032Q104 | WHWK | Aadi Bioscience, Inc. | $1.2M | 0.17% | 526,329 | Common | SOLE |
| 81663L200 | WGS | GeneDx Holdings Corp. | $945,904 | 0.13% | 103,604 | Common | SOLE |
| 04963C209 | ATRC | AtriCure Inc. | $815,165 | 0.11% | 26,797 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.